A population-based study of COVID-19 mortality risk in US cancer patients.

Kyle A ManiXue WuDaniel E SprattMing WangNicholas G Zaorsky

Published in: Journal of the National Cancer Institute (2024)

We observed that people living with cancer are at 2 times greater risk of dying from COVID-19 compared with the general US population. This work may be used by physicians and public health officials in the creation of survivorship programs that mitigate the risk of COVID-19 mortality.

Keyphrases

coronavirus disease
sars cov
public health
primary care
papillary thyroid
palliative care
respiratory syndrome coronavirus
cardiovascular events
type diabetes
squamous cell carcinoma
risk factors
squamous cell